Pietro Forestieri

Pietro Forestieri

Auto-generated profile, based on publicly available information

Pietro Forestieri

Department of Clinical Medicine and Surgery, Breast Unit, University of Naples Federico II, Italy

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
AGA Genco
A Genco
TBT Bruni
T Bruni
SDS B Doldi
S B Doldi
PFP Forestieri
P Forestieri
MMM Marino
M Marino
NBN Basso
N Basso

1 December 2007 in Annals of Surgery
Verified
Journal Article
Closed access
MMMario Morino
Mario Morino
MTMauro Toppino
Mauro Toppino
PFPietro Forestieri
Pietro Forestieri
LALuigi Angrisani
Luigi Angrisani
MAMarco Allaix
Marco Allaix
NSNicola Scopinaro
Nicola Scopinaro
To define mortality rates and risk factors of different bariatric procedures and to identify strategies to reduce the surgical risk in patients undergoing bariatric surgery. Postoperative mortality is a rare event after bariatric surgery. Therefore, comprehensive data on mortality are lacking in the literature. A retrospective analysis of a large prospective database was carried out. The Italian Society of Obesity Surgery runs a National Registry on bariatric surgery where all procedures performed by members of the Society should be included prospectively. This Registry represents at present the largest database on bariatric surgery worldwide. Between January 1996 and January 2006, 13,871 bariatric surgical procedures were included: 6122 adjustable silicone gastric bandings (ASGB), 4215 vertical banded gastroplasties (VBG), 1106 gastric bypasses, 1988 biliopancreatic diversions (BPD), 303 biliointestinal bypasses, and 137 various procedures. Sixty day mortality was 0.25%. The type of surgical procedure significantly influenced (P < 0.001) mortality risk: 0.1% ASGB, 0.15% VBG, 0.54% gastric bypasses, 0.8% BPD. Pulmonary embolism represented the most common cause of death (38.2%) and was significantly higher in the BPD group (0.4% vs. 0.07% VBG and 0.03% ASGB). Other causes of mortality were the following: cardiac failure 17.6%, intestinal leak 17.6%, respiratory failure 11.8%, and 1 case each of acute pancreatitis, cerebral ischemia, bleeding gastric ulcer, intestinal ischemia, and internal hernia. Therefore, 29.4% of patients died as a result of a direct technical complication of the procedure. Additional significant risk factors included open surgery (P < 0.001), prolonged operative time (P < 0.05), preoperative hypertension (P < 0.01) or diabetes (P < 0.05), and case load per Center (P < 0.01). Mortality after bariatric surgery is a rare event. It is influenced by different risk factors including type of surgery, open surgery, prolonged operative time, comorbidities, and volume of activity. In defining the best bariatric procedure for each patient the different mortality risks should be taken into account. Choice of the procedure, prevention, early diagnosis, and therapy for cardiovascular complications may reduce postoperative mortality.

1 November 2010 in Obesity
Verified
Journal Article
Closed access
PDF file
Rosanna MartinelliRosanna Martinelli
Rosanna Martinelli
CNCarmela Nardelli
Carmela Nardelli
VPVincenzo Pilone
Vincenzo Pilone
TBTonia Buonomo
Tonia Buonomo
RLRosario Liguori
Rosario Liguori
LSLucia Sacchetti
Lucia Sacchetti

4 December 2002 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
LAL. Angrisani
L. Angrisani
FFF. Furbetta
F. Furbetta
SDS.B. Doldi
S.B. Doldi
NBN. Basso
N. Basso
MLM. Lucchese
M. Lucchese
MLM. Lorenzo
M. Lorenzo

1 July 2013 in European Journal of Endocrinology
Verified
Journal Article
Closed access
ARAnna De Rosa
Anna De Rosa
MMMaria Ludovica Monaco
Maria Ludovica Monaco
Mario CapassoMario Capasso
Mario Capasso
PFPietro Forestieri
Pietro Forestieri
VPVincenzo Pilone
Vincenzo Pilone
ADAurora Daniele
Aurora Daniele
Objective: Adiponectin is an adipocytokine that exerts beneficial effects on obesity and related disorders by two receptors (ADIPORs). Adiponectin is produced as a monomer that circulates in serum as different oligomers. The oligomerization state and the tissue expression of adiponectin and ADIPORs are linked to its biological activities. In this study, the levels of total adiponectin and its oligomers were evaluated in relation to obesity and surgical weight loss. The expression of adiponectin and ADIPORs was analyzed in visceral and subcutaneous adipose tissues of obese patients.Design and methods: In 25 obese patients and 44 age- and sex-matched controls, the serum levels of adiponectin and its oligomers were measured and compared by ELISA, western blotting, and gel filtration. The expression of adiponectin and ADIPORs in both adipose tissues was evaluated by real-time quantitative PCR and western blotting.Results: The amount of each adiponectin oligomer, including the monomer, increases after weight loss. The reduced circulating levels of adiponectin and its oligomers are not associated with the adipose tissue depot-specific expression of adiponectin and ADIPORs.Conclusions: Our results suggest that in patients, adiposity is associated with the serum concentrations of adiponectin and its oligomers but not with adipose tissue depot-specific expression of adiponectin and ADIPORs. In particular, the increase in adiponectin monomer levels could probably be related to the improvement of the whole-body energy metabolism then being involved in the improvement of adipose tissue function after weight loss. This work indicates the importance of assessing the whole adiponectin oligomeric profile as further potential indicators of adipose tissue functions in obesity.

1 July 2014 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
Giuseppe GalloroGiuseppe Galloro
Giuseppe Galloro
LMLuca Magno
Luca Magno
MMMario Musella
Mario Musella
RMRaffaele Manta
Raffaele Manta
AZAngelo Zullo
Angelo Zullo
PFPietro Forestieri
Pietro Forestieri